Revolutionizing the pathology workflow from biopsy to histopathological image
SurgiVance Inc. has raised $2.2M in total funding. The most recent round was Grant. The last funding was announced in July 2025.
SurgiVance Inc.'s investors include Portland Seed Fund.
SurgiVance Inc. is headquartered in New York, United States.
Revolutionizing the pathology workflow from biopsy to histopathological image
SurgiVance Inc. is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"SurgiVance Inc. — Funding & Investors." VCBacked, July 22, 2025, https://www.vcbacked.co/company/surgivance-inc. Accessed August 13, 2026.
VCBacked. (2025). SurgiVance Inc. — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/surgivance-inc
{{cite web |title=SurgiVance Inc. — Funding & Investors |url=https://www.vcbacked.co/company/surgivance-inc |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated